Last night, London-based Keregen were crowned the 2015 winners of OneStart Europe, receiving the £100k grand prize – and even better, a year’s free membership of the BIA!

Keregen develops first-in-class medicines for the prevention and treatment of neurodegenerative disease and is currently focussed on disease modifiers for Parkinson’s. Watch Jemma Gatliff, co-founder and CEO of Keregen, give some background to the company in their semi-finalist video from earlier in the competition.

Find out more about OneStart from our previous video showcase here, and read our guest blog from 2013 OneStart winner, Puridify’s Oliver Hardick, here.

Do you have a video you would like the sector to see? Contact us.